Pneumonitis associated to methotrexate;Neumonitis secundaria a metotrexate

Anales de Medicina Interna

Volumn 25, Issue 1, 2008, Pages 27-30

  Sáenz Abad, Daniel ^a   Ruiz Ruiz, F J ^a   Monon Ballarin S ^a   Mozota Duarte, J ^a   Marquina Barcos, A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Lung toxicity; Methotrexate; Pneumonitis

Indexed keywords

METHOTREXATE; METHYLPREDNISOLONE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CASE REPORT; CLINICAL FEATURE; COUGHING; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; HUMAN; INFECTION; INTERSTITIAL PNEUMONIA; MALAISE; PHYSICAL EXAMINATION; THORAX RADIOGRAPHY;

ADRENAL CORTEX HORMONES; AZATHIOPRINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; METHOTREXATE; METHYLPREDNISOLONE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 42049121678     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gauhar UA, Gaffo AL, Alarcon GS. Pulmonary manifestations of rheumatoid arthritis. Semin Respir Crit Care Med 2007; 96: 1641-5
2. Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. Q J Med 2001; 94: 309-19.
3. Swierkot J, Szechinski J. Methotrexate in rheumatoid arthritis. Pharmacol Rep 2006; 58: 473-92
4. Llamas P, Busto M J, Diez JL, Cabrera R, Regidor C, Fores R, et al. Eficacia de distintos tratamientos en el manejo de la púrpura trombocitopénica idiopática (PTI) del adulto. Sangre 1995; 40: 181-85
5. Alarcon, GS, Kremer, JM, Macaluso, M, Weinblatt ME, Cannon GW, Palmer WR, et al. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis: A multicenter, case-control study. Ann Intern Med 1997; 127:356-64
6. Imokawa S, Colby T.V, Leslie K.O, Helmers R.A. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15: 373-81
7. Saravanan V, Kelly C. A. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology 2004;43:143-47
8. Jardine DL, Colls BM. Hodgkin's disease following methotrexate therapy for rheumatoid arthritis. N Z Med J 2002; 115: 293-4
9. Kaneko Y, Suwa A, Ikeda Y, Hirakata M. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature. Mod Rheumatol 2006; 16: 36-38
10. Cho I, Mori S, Imamura F, Kiyofuji C, Sugimoto M. Methotrexate pneumonia lacking dyspnea and radiographic interstitial patterns during treatment for early rheumatoid arthritis: bronchoalveolar lavage and transbronchial lung biopsy in a differential diagnosis. Mod Rheumatol 2007; 17: 256-61
11. Barrera P, Laan RF, von-Riel Pl, Dekhuijzen PN, Boerbooms AM, van de Putte LB. Metotrexate-related pulmonary complication in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 434-39
12. Kremer Jm, Alarcon GS, Weinblatt ME, Kaymakcian MV, Macaluso M, Cannon GW, et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 1997; 40: 1829-37
13. Rossi SE, Erasmus J.J, McAdams H.P, Sporn T.A, Goodman P.C. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20:1245-59
14. Arakawa H, Yamasaki M, Kurihara Y, Yamada H, Nakajima Y. Methotrexate-induced pulmonary injury: serial CT findings. J Thorac Imaging 2003; 18: 231-6
15. Searles G, McKendry RJR. Methotrexate penumonitis in rheumatoid arthritis: potential risk factors. Four cases and review of the literature. J Rheumatol 1987; 14: 1164-1171.
16. Balk RA. Methotrexate-induced lung injury. In: UpToDate, Rose BD (Ed), UpToDate, Waltham, USA, 2006
17. Suwa A, Hirakata M, Satoh S, Mimori T, Utsumi K, Inada S. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with intravenous cyclophosphamide therapy. Clin Exp Rheumatol 1999; 17: 335-38
18. Morgan SL, Oster RA, Lee JY, Alarcon GS, Baggott JE. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis Rheum 2004; 50: 3104-11
19. Whittle S. L, Hughes R. A. Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review. Rheumatology 2004; 43: 267-71